Micro Biomics Private Limited is a biotechnology company transforming high-throughput genomic data into actionable clinical intelligence.
Enable precision infectious disease diagnostics through targeted genomics, bioinformatics, and machine learning—delivering rapid resistance and pathogen profiles directly to clinicians.
Build a sovereign molecular intelligence platform for infectious diseases, establishing a genomic foundation to expand into Oncology, Rare Genetic Diseases, and Population Genomics.
Rigorous genomic pipelines engineered for reproducibility, strict variant calling thresholds, and clinical accuracy.
Adhering to AI management standards and ISO quality protocols to support clinical decision-making.
Leveraging bioinformatics to solve high-burden health challenges, starting with Tuberculosis and AMR.
Tuberculosis Genomics, Antimicrobial Resistance (AMR), and Hospital-Acquired Infection surveillance.
Expanding genomic variant engines into targeted liquid biopsy diagnostics and rare disease profiling.
Large-scale epidemiological insights and API integrations for health system infrastructure.
Our founders combine academic research rigor, industrial execution, and deep technology leadership to advance precision diagnostics.
Co-Founder & Chief Scientific Advisor
Professor in Biosciences & Bioengineering at IIT Bombay and Head of WITC. With 25+ years in NMR spectroscopy and biopharmaceuticals, he has authored 70+ publications and holds 3 patents. He brings deep scientific leadership to advance precision microbiome diagnostics.
Co-Founder & Chief Executive Officer
Seasoned executive with 30+ years driving business strategy, technology execution, and global program management. He brings a rare blend of technical depth and strategic insight to architect resilient organizations and align innovation with business value.
Co-Founder & Chief Technology Officer
With 30+ years in AI, Machine Learning, and data engineering, he leads the technology vision at Micro Biomics. He builds secure, scalable platforms that convert complex genomic and microbiome data into actionable clinical insights for precision care.
Whether you are a healthcare provider, research institution, prospective team member, or investor, explore how our platform transforms molecular data.
